2021
DOI: 10.15789/2220-7619-fod-1684
|View full text |Cite
|
Sign up to set email alerts
|

Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation

Abstract: The novel coronavirus (SARS-CoV-2) pandemic, dubbed COVID-19, has become one of the most serious challenges for human populations in the vast majority of countries worldwide. Rapid spreading and increased mortality related to it required new approaches to manage epidemic processes on a global scale. One of such approaches was based on analyzing SARS-CoV-2 seroprevalence associated with COVID-19. Our aim was to summarize the results on assessing seroprevalence to the SARS-CoV-2 nucleocapsid antigen (Nc) in resi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

5
2

Authors

Journals

citations
Cited by 32 publications
(11 citation statements)
references
References 55 publications
1
10
0
Order By: Relevance
“…From a practical point of view, epidemiological analysis of the state of collective immunity using serological methods (for determining the prevalence of SARS-CoV-2 Abs) and other epidemiological analysis approaches are more appropriate [ 12 , 13 ]. This article continues our previous publications analyzing SARS-CoV-2 Ab seroprevalence, such as our cross-sectional study of herd immunity in the St. Petersburg population [ 14 ] conducted in the early period of COVID-19 incidence (13–20 June 2020), as well as longitudinal seromonitoring of the population in 26 regions of Russia [ 15 , 16 , 17 , 18 , 19 , 20 ]. Features of seroprevalence in Belarus and Kyrgyzstan (2020–21) were also analyzed [ 21 , 22 ].…”
Section: Introductionsupporting
confidence: 66%
“…From a practical point of view, epidemiological analysis of the state of collective immunity using serological methods (for determining the prevalence of SARS-CoV-2 Abs) and other epidemiological analysis approaches are more appropriate [ 12 , 13 ]. This article continues our previous publications analyzing SARS-CoV-2 Ab seroprevalence, such as our cross-sectional study of herd immunity in the St. Petersburg population [ 14 ] conducted in the early period of COVID-19 incidence (13–20 June 2020), as well as longitudinal seromonitoring of the population in 26 regions of Russia [ 15 , 16 , 17 , 18 , 19 , 20 ]. Features of seroprevalence in Belarus and Kyrgyzstan (2020–21) were also analyzed [ 21 , 22 ].…”
Section: Introductionsupporting
confidence: 66%
“…Currently, a large number of works, of varying quality, have been published on the problem of population immunity to SARS-CoV-2, as summarized in a number of overview articles and meta-reviews [ 9 , 47 , 60 ]. Published works on population seroprevalence in a number of countries or regions have been provided: China [ 61 ]; Israel [ 10 ]; the Near and Middle East [ 9 , 62 , 63 ]; most countries of Europe [ 60 ]; North and Latin America [ 64 , 65 ]; Australia [ 66 ]; and Russia [ 17 , 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…Perhaps the publication of this English version of the work will help to fill in information gaps to some extent. Further, it is worth mentioning that a large group of authors have already published 16 articles in Russian publications under the auspices of the head of Rospotrebnadzor, Professor A. Y. Popova [ 17 , 18 , 19 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations